XORTX Therapeutics Inc.
XRTX
$0.87
-$0.1026-10.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.30M | 3.08M | 3.84M | 3.45M | 5.07M |
| Total Receivables | 13.10K | 22.80K | 30.90K | 60.70K | 68.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 96.50K | 207.30K | 639.00K | 237.00K | 88.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 48.10K | 157.10K | 323.40K | -- |
| Total Current Assets | 2.41M | 3.36M | 4.66M | 4.07M | 5.23M |
|
|
|||||
| Total Current Assets | 2.41M | 3.36M | 4.66M | 4.07M | 5.23M |
| Net Property, Plant & Equipment | 54.20K | 73.80K | 22.20K | 23.90K | 42.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 185.70K | 168.90K | 166.00K | 175.30K | 171.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M |
| Total Assets | 3.85M | 4.80M | 6.05M | 5.47M | 6.64M |
|
|
|||||
| Total Accounts Payable | 110.70K | 270.00K | 185.10K | 195.80K | 394.00K |
| Total Accrued Expenses | 215.50K | 168.00K | 141.80K | 87.60K | 131.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 61.50K | -- | 14.00K | 11.50K | 28.50K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 387.80K | 437.90K | 340.90K | 294.90K | 553.80K |
|
|
|||||
| Total Current Liabilities | 387.80K | 437.90K | 340.90K | 294.90K | 553.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 83.70K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.33M | 1.57M | 3.22M | 531.00K | -- |
| Total Liabilities | 1.72M | 2.09M | 3.56M | 825.90K | 553.80K |
|
|
|||||
| Common Stock & APIC | 17.87M | 17.87M | 17.87M | 17.06M | 17.06M |
| Retained Earnings | -21.29M | -20.70M | -20.87M | -17.85M | -20.55M |
| Treasury Stock & Other | 5.55M | 5.54M | 5.49M | 5.44M | 9.58M |
| Total Common Equity | 2.13M | 2.70M | 2.49M | 4.64M | 6.09M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.13M | 2.70M | 2.49M | 4.64M | 6.09M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.13M | 2.70M | 2.49M | 4.64M | 6.09M |
|
|
|||||
